Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases
Open accessThe DOI matches its Crossref record; 101 of the 106 references it cites were found in a registry or an index; 15 of the 55 sources its claims cite were checked for support.
Abstract
Peyronie's disease (PD) affects the penile albuginea, resulting in penile deformity, pain, erectile dysfunction (ED), and an anxious-depressive state. PD diagnosis involves a thorough medical history, penile palpation, documentation of the penile deformation, a dynamic penile echo color Doppler ultrasound (PCDU), and the completion of questionnaires for the evaluation of pain, ED, and psychometric tests. The aim of this study was to evaluate the symptoms of PD and their prevalence in PD patients in the active phase who had access to our andrology clinic. Inclusion criteria: availability of data on patients diagnosed with PD, including detailed medical history, blood tests, penile palpation, photographic documentation of penile deformity, and penile PCDU. Exclusion criteria: PD patients in the stable phase or those without the specified tests and data mentioned above. Our study found a higher prevalence of PD in younger patients (24.2%), a higher coexistence of PD with chronic prostatitis (35.6%), a higher percentage of cases of association between penile deformity and penile curvature (84.4%), a higher prevalence of "significant anxiety" (88.4%), a higher presence of plaque calcification (35.6%), and the detection of a longer duration of the first phase of PD (>18 months). The most frequently observed type of penile curvature was dorsal, followed by left lateral, right lateral, and, less commonly, ventral. We observed a significant statistical correlation between patient age and IIEF score, indicating that patients over the age of 40 years are at a higher risk of experiencing ED. We found a strong statistical relationship between VAS score and age. As age increases, the VAS score decreases, suggesting that younger patients reported more penile pain compared to those who were older than 40 years. Furthermore, we found that penile pain has a significant impact on the psychological state of PD patients. We also found that 38.8% of PD patients suffered from severe anxiety. In relation to this, psychotherapy should be integrated into PD treatment to improve the quality of life and treatment adherence.
Overview
CoChat Summary
## TL;DR
This retrospective study analyzed 564 men with Peyronie’s disease in the active phase and found substantial burdens of curvature, pain, erectile dysfunction, and psychological distress. The authors report that 24.2% of cases were in men aged 40 or younger, 39.8% had ED, and 38.8% had severe anxiety.
## Key findings
- Among 564 PD patients, the mean age was 49.54 years (SD ± 12.25); 137 patients (24.2%) were aged 40 or younger, and 427 (75.7%) were older than 40.
- Erectile dysfunction was found in 225 cases (39.8%); among those with both PD and ED, 127/225 (56.4%) reported ED before PD onset.
- Penile pain was present in 53.3% of cases, and 38.8% of patients had “severe” anxiety; significant depression was reported in 57.6%.
- The most frequent penile curvature was dorsal, followed by left lateral, right lateral, and ventral; penile shortening was the most common deformity (498 cases, 88.2%), and multifocal plaque occurred in 91/564 cases (16.1%).
- Significant correlations were reported between age and pain (VAS; p = 0.0070), age and curvature degree (p = 0.0001), age and IIEF score, and curvature severity with the psychometric scores; plaque volume correlated with curvature degree and time since onset, but IIEF did not correlate with plaque volume, VAS did not correlate with time since onset, and ED severity did not correlate with curvature severity or pain severity.
## Methods
- Retrospective analysis of an andrology clinic database; 564 patients with Peyronie’s disease seen from January 2013 to February 2024, limited to patients in the active phase with required data available.
- Data collected included medical history, blood tests, penile palpation, photographic documentation and goniometric curvature measurement, dynamic penile echo color Doppler ultrasound, and questionnaires: VAS, IIEF, GAD-7, PHQ-9, and PDQ symptom bother.
- Statistical analysis used mean/SD, chi-squared tests, unpaired t-tests, Pearson correlations, and post hoc power analysis; significance threshold was p < 0.05.
## Limitations
- The paper does not state a dedicated limitations section; this is evident from the text.
- Evident from the design: the study is retrospective and from a single clinic database, so causal inference is limited and selection/referral bias may affect generalizability.
- The authors explicitly note possible bias and a “gap in knowledge” in prior literature, including uncertainty about disease phase duration and inconsistent plaque measurement methods; this is stated in the Discussion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 1 Not valid · 8 Not checked · 46 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In our research, we also found a slightly higher psychosexual impact (PDQ bother mean score = 8.8) compared to those reported by other authors (6.3–8.0) [60,64,83].”
§ Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases > 4. Discussion
What the sources say
- Not checked — no full text of the sourcecites [60] Hellstrom, 2013, Bother and distress associated with Peyronie’s disease: Validation of the Peyronie’s disease questionnaire, J. Urol. source
- Not checked — no full text of the sourcecites [64] Cilio, 2023, The symptomatic burden of Peyronie’s disease at presentation according to patient age: A critical analysis of the Peyronie’s disease questionnaire (PDQ) domains, Andrology source
- Supportedcites [83] Goldstein, 2017, Changes in the Effects of Peyronie’s Disease after Treatment with Collagenase Clostridium histolyticum: Male Patients and Their Female Partners, Sex. Med. source
The Results (Table 1) report a baseline mean PDQ symptom bother score of 6.3, the lower end of the 6.3–8.0 range attributed collectively to three cited studies. The citing authors’ score of 8.8 is their own finding, not a finding attributed to this source. (LLM, conf=0.92)
plainn = 564- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found a statistically significant correlation (Pearson coefficient) between the VAS score and age.”
- Also stated in: § 4. Discussion · boosted
“Additionally, we discovered a highly significant statistical correlation between the VAS score and age.”
§ Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases > 3. Results
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, we found no statistically significant correlation between the IIEF score and the time since the disease onset.”
§ Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases > 4. Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also did not observe a statistically significant correlation between the severity of ED (as measured by the IIEF score) and the severity of penile curvature.”
§ Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases > 4. Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The most frequent type of penile deformity detected was penile shortening (498 cases, 88.2%).”
- Also stated in: § 5. Conclusions · plain
“Penile shortening was the most common deformity found, followed by the penile hourglass, divot, torsion, and flail penis.”
§ Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases > 4. Discussion
plainn = 498- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 5. Conclusions · plain
26 more claims
Create a free account to see all 62 claims and to verify the 8 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 9
- The quote only partly states this claim. 1
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849 · cited 2×
“ED was considered present if the score was 26 [57].”
BackgroundThe epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
The prevalence of Peyronie's disease: results of a large survey
Schwarzer, U., Sommer, F., Klotz, T., Braun, M., Reifenrath, B., & Engelmann, U. (2001) · BJU International · doi:10.1046/j.1464-4096.2001.02436.x · Cited by 440
An Analysis of the Natural History of Peyronie’s Disease
Mulhall, J. P., Schiff, J., & Guhring, P. (2006) · Journal of Urology · doi:10.1016/s0022-5347(06)00270-9 · Cited by 417
Peyronie’s Disease: AUA Guideline
Nehra, A., Alterowitz, R., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., McVary, K. T., Miner, M. M., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.05.098 · Cited by 416
Krieger, J. N., Lee, S. W. H., Jeon, J., Cheah, P. Y., Liong, M. L., & Riley, D. E. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.028 · Cited by 389
Proposal: Trauma as the Cause of the Peyronie's Lesion
Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65361-8 · Cited by 381
Kahl, C., & Cleland, J. A. (2005) · Physical Therapy Reviews · doi:10.1179/108331905x55776 · Cited by 368
EAU guidelines on penile curvature
Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Salonia, A., Vardi, Y., & Wespes, E. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.040 · Cited by 309
The Incidence of Peyronie’s Disease in Rochester, Minnesota, 1950 through 1984
Lindsay, M. B., Schain, D. M., Grambsch, P., Benson, R. C., Beard, C. M., & Kurland, L. T. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37988-0 · Cited by 265
The Chronology of Depression and Distress in Men with Peyronie's Disease
Nelson, C. J., Diblasio, C., Kendirci, M., Hellstrom, W., Guhring, P., & Mulhall, J. P. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00895.x · Cited by 255
Evidence-Based Management Guidelines on Peyronie's Disease
Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.062 · Cited by 227
DiBenedetti, D. B., Nguyen, D., Zografos, L., Ziemiecki, R., & Zhou, X. (2011) · Advances in Urology · doi:10.1155/2011/282503 · Cited by 226
A Retrospective Review of 307 Men With Peyronie’s Disease
Kadioglu, A., Tefekli, A., Erol, B., Oktar, T., Tunc, M., & Tellaloglu, S. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64578-8 · Cited by 225
Hellstrom, W. J. G., Feldman, R., Rosen, R. C., Smith, T., Kaufman, G., & Tursi, J. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.090 · Cited by 210 · cited 6×
“…GAD-7 score > 9 [58]; PHQ-9 = Patient Health Questionnaire-9, for depressive measurement, where significant depression is present when PHQ-9 score > 9 [59]; PDQ bother = Peyronie’s Disease Questionnaire/symptom bother to evaluate the psychosexual impact, where the score ranges from 0 to 30 [60,61].”
BackgroundResultInfluentialRisk Factors for Emotional and Relationship Problems in Peyronie's Disease
Smith, J. F., Walsh, T. J., Conti, S. L., Turek, P., & Lue, T. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00949.x · Cited by 206 · cited 1×
“%) was higher than the rates reported in other studies in the literature that refer to “distress” and “emotional” concerns (80–81% of cases) [80,81].”
ResultPENILE TRAUMA: AN ETIOLOGIC FACTOR IN PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION
Jarow, J. P., & Lowe, F. C. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64222-8 · Cited by 202
Psychological Impact of Peyronie's Disease: A Review
Nelson, C. J., & Mulhall, J. P. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02999.x · Cited by 187
Peyronie's Disease: Etiology, Medical, and Surgical Therapy
HELLSTROM, W. J. G., & BIVALACQUA, T. J. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb03387.x · Cited by 170
Peyronie’s Disease: Prevalence and Association with Cigarette Smoking
La Pera, G., Pescatori, E. S., Calabrese, M., Boffini, A., Colombo, F., Andriani, E., Natali, A., Vaggi, L., Catuogno, C., Giustini, M., et al. (2001) · European Urology · doi:10.1159/000049830 · Cited by 165
Taylor, F. L., & Levine, L. A. (2007) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.08.017 · Cited by 151
Surgical Treatment of Peyronie’s Disease: A Critical Analysis
Kadıoğlu, A., Akman, T., Şanlı, Ö., Gürkan, L., Çakan, M., & Çeltik, M. (2006) · European Urology · doi:10.1016/j.eururo.2006.04.030 · Cited by 149
Clinical presentations of Peyronie's disease
Pryor, J. P., & Ralph, D. J. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900877 · Cited by 139
The Prevalence of Peyronie's Disease in the United States: A Population-Based Study
Stuntz, M., Perlaky, A., des Vignes, F., Kyriakides, T., & Glass, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150157 · Cited by 137
Standard Operating Procedures for Peyronie's Disease
Levine, L. A., & Burnett, A. L. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.03003.x · Cited by 134
Potential Therapeutic Effect of Antioxidant Therapy in Shock and Inflammation
Cuzzocrea, S., Thiemermann, C., & Salvemini, D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365396 · Cited by 129
Martínez-Salamanca, J. I., Egui, A., Moncada, I., Minaya, J., Ballesteros, C. M., del Portillo, L., Sola, I., & Carballido, J. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12400 · Cited by 129
Weidner, W., Schroeder-Printzen, I., Weiske, W.-H., & Vosshenrich, R. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65370-9 · Cited by 121
Lee, J. S., & Chung, B. H. (2007) · Urologia Internationalis · doi:10.1159/000100836 · Cited by 120
The role of vacuum pump therapy to mechanically straighten the penis in Peyronie’s disease
Raheem, A. A., Garaffa, G., Raheem, T. A., Dixon, M., Kayes, A., Christopher, N., & Ralph, D. (2010) · BJU International · doi:10.1111/j.1464-410x.2010.09365.x · Cited by 108
Prevalence of Peyronie’s Disease Among Patients With Erectile Dysfunction
El‐Sakka, A. I. (2005) · European Urology · doi:10.1016/j.eururo.2005.10.026 · Cited by 108
Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil
Rhoden, E., Telöken, C., Ting, H., Lucas, M., Ros, C. T. D., & Souto, C. (2001) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900727 · Cited by 107
A Critical Analysis of Nonsurgical Treatment of Peyronie’s Disease
Hauck, E. W., Thorsten Diemer, A., Schmelz, H. U., & Weidner, W. (2006) · European Urology · doi:10.1016/j.eururo.2006.02.059 · Cited by 105
Critical analysis of surgery for Peyronieʼs disease
Kendirci, M., & Hellstrom, W. J. (2004) · Current Opinion in Urology · doi:10.1097/00042307-200411000-00015 · Cited by 103
Accuracy and repeatability of prostate volume measurements by transrectal ultrasound
Eri, L. M., Thomassen, H., Brennhovd, B., et al. (2002) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500568 · Cited by 100
The Natural History of Peyronie's Disease: An Ultrasonography-Based Study
Bekos, A., Arvaniti, M., Hatzimouratidis, K., Moysidis, K., Tzortzis, V., & Hatzichristou, D. G. (2007) · European Urology · doi:10.1016/j.eururo.2007.07.013 · Cited by 96
Davila, H. H., Magee, T. R., Vernet, D., Rajfer, J., & Gonzalez-Cadavid, N. F. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.030833 · Cited by 91
Autophotography in evaluation of functional penile disorders
Kelâmi, A. (1983) · Urology · doi:10.1016/0090-4295(83)90210-8 · Cited by 89
Treatment of Peyronie's disease with oral pentoxifylline
Brant, W. O., Dean, R. C., & Lue, T. F. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0409 · Cited by 87
Peyronie’s disease: Contemporary evaluation and management
Ziegelmann, M. J., Bajic, P., & Levine, L. A. (2020) · International Journal of Urology · doi:10.1111/iju.14230 · Cited by 86
Psychological aspects of Peyronie’s disease
Terrier, J. E., & Nelson, C. J. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.05.14 · Cited by 85 · cited 1×
“%) was higher than the rates reported in other studies in the literature that refer to “distress” and “emotional” concerns (80–81% of cases) [80,81].”
ResultGene expression in Peyronie's disease
Gonzalez-Cadavid, N. F., Magee, T. R., Ferrini, M., Qian, A., Vernet, D., & Rajfer, J. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900873 · Cited by 84
Fibromatosis of the plantar fascia
Pickren, J. W., Smith, A. G., Stevenson, T. W., & Stout, A. P. (1951) · Cancer · doi:10.1002/1097-0142(195107)4:4<846::aid-cncr2820040422>3.0.co;2-n · Cited by 81
Congenital Penile Deviation and its Treatment with the Nesbit‐Kelåmi Technique
Kelâmi, A. (1987) · British Journal of Urology · doi:10.1111/j.1464-410x.1987.tb05496.x · Cited by 81
Role of oxidative stress and antioxidants in Peyronie’s disease
Sikka, S. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900880 · Cited by 77 · cited 3×
“In the scientific literature, several articles have appeared in the 21st century that have clarified the important role that “oxidative stress” plays in the pathophysiology of PD [15–22].”
BackgroundIncidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy
de Bree, E., Zoetmulder, F. A. N., Keus, R. B., Peterse, H. L., & van Coevorden, F. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2002.11.002 · Cited by 76
Understanding the course of Peyronie's disease
Garaffa, G., Trost, L. W., Serefoglu, E. C., Ralph, D., & Hellstrom, W. J. G. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12129 · Cited by 75 · cited 2×
“In the scientific literature, it is reported that PD generally stabilizes at between 12 and 18 months from the onset of the disease [15,31,34,51,99,100].”
BackgroundLevine, L., Rybak, J., Corder, C., & Farrel, M. R. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12334 · Cited by 69
Nguyen, H. M. T., Anaissie, J., DeLay, K. J., Yafi, F. A., Sikka, S. C., & Hellstrom, W. J. G. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.08.008 · Cited by 69
Induratio Penis Plastica (Peyronie's Disease): Clinical Features and Etiology
Byström, J., & Rubio, C. (1976) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365597609179648 · Cited by 67
The pathophysiology of Peyronie’s disease
El-Sakka, A. I., Salabas, E., Dinçer, M., & Kadioglu, A. (2013) · Arab Journal of Urology · doi:10.1016/j.aju.2013.06.006 · Cited by 64
Paulis, G., & Brancato, T. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812798889321 · Cited by 60 · cited 1×
“In the second phase, known as the chronic “stabilized phase”, penile pain decreases and the plaque size and deformity stabilize [2,15,19,21,22,30,31].”
BackgroundSelf-citationThe Natural History of Peyronie’s Disease
Di Maida, F., Cito, G., Lambertini, L., Valastro, F., Morelli, G., Mari, A., Carini, M., Minervini, A., & Cocci, A. (2021) · The World Journal of Men's Health · doi:10.5534/wjmh.200065 · Cited by 59
ESSM Position Statement on Surgical Treatment of Peyronie's Disease
Osmonov, D., Ragheb, A., Ward, S., Blecher, G., Falcone, M., Soave, A., Dahlem, R., van Renterghem, K., Christopher, N., Hatzichristodoulou, G., et al. (2022) · Sexual Medicine · doi:10.1016/j.esxm.2021.100459 · Cited by 56
Review of Management Options for Active-Phase Peyronie’s Disease
Brimley, S. C., Yafi, F. A., Greenberg, J., Hellstrom, W. J. G., Tue Nguyen, H. M., & Hatzichristodoulou, G. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.09.007 · Cited by 46
Intralesional verapamil for the treatment of Peyronie's disease: a review
Levine, L. A., & Estrada, C. R. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900917 · Cited by 45
Paulis, G., Romano, G., Paulis, L., & Barletta, D. (2017) · Advances in Urology · doi:10.1155/2017/4653512 · Cited by 44 · cited 1×
“In the second phase, known as the chronic “stabilized phase”, penile pain decreases and the plaque size and deformity stabilize [2,15,19,21,22,30,31].”
BackgroundSelf-citation(1991) · PubMed · Cited by 44
Richards, G. D., Goldenberg, E., Pek, H., & Gilbert, B. R. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12396 · Cited by 43
Factors Affecting the Degree of Penile Deformity in Peyronie Disease: An Analysis of 1001 Patients
Kadioglu, A., Sanli, O., Akman, T., Canguven, O., Aydin, M., Akbulut, F., & Kucukdurmaz, F. (2011) · Journal of Andrology · doi:10.2164/jandrol.110.011031 · Cited by 42
Penile Sonographic and Clinical Characteristics in Men with Peyronie’s Disease
Smith, J. F., Brant, W. O., Fradet, V., Shindel, A. W., Vittinghoff, E., Chi, T., Huang, Y.-C., Davis, C. B., Conti, S., & Lue, T. F. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01438.x · Cited by 40
Serefoglu, E. C., Smith, T. M., Kaufman, G. J., Liu, G., Yafi, F. A., & Hellstrom, W. J. G. (2017) · Urology · doi:10.1016/j.urology.2017.05.029 · Cited by 39 · cited 5×
“In the literature on this topic, we found consistent results [60,84].”
BackgroundResultInfluentialTreatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate
Levine, L. A., & Latchamsetty, K. C. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900912 · Cited by 38
Shiraishi, K., Shimabukuro, T., & Matsuyama, H. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02868.x · Cited by 38
Paulis, G., Barletta, D., Turchi, P., Vitarelli, A., Dachille, G., Fabiani, A., & Romano, G. (2015) · Research and Reports in Urology · doi:10.2147/rru.s97194 · Cited by 37
Self-citationGoldstein, I., Knoll, L. D., Lipshultz, L. I., Smith, T., Kaufman, G. J., & McMahon, C. G. (2017) · Sexual Medicine · doi:10.1016/j.esxm.2017.02.001 · Cited by 33
Erectile Function Profiles in Men With Peyronie’s Disease
Deveci, S., Palese, M., Parker, M., Guhring, P., & Mulhall, J. P. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)01018-9 · Cited by 33
Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease
Bivalacqua, T. J., Champion, H. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900872 · Cited by 31
Shockwave Therapy in the Treatment of Peyronie’s Disease
Krieger, J. R., Rizk, P. J., Kohn, T. P., & Pastuszak, A. W. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.02.001 · Cited by 28
Margolin, E. J., Pagano, M. J., Aisen, C. M., Onyeji, I. C., & Stahl, P. J. (2018) · Sexual Medicine · doi:10.1016/j.esxm.2018.07.003 · Cited by 27
Paulis, G., Barletta, D., Turchi, P., Vitarelli, A., Dachille, G., Fabiani, A., & Gennaro, R. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 27
Self-citationSurgical correction of Peyronie's disease via tunica albuginea plication: long‐term follow‐up
Seveso, M., Melegari, S., Francesco, O. D., Macchi, A., Otero, J., Taverna, G., & Bozzini, G. (2017) · Andrology · doi:10.1111/andr.12431 · Cited by 26
The Clinical Characteristics of Peyronie’s Patients with Notching Deformity
Cakan, M., Akman, T., Oktar, T., Gurkan, L., Celtik, M., & Kadioglu, A. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00258.x · Cited by 25
Realtime-elastosonography of the penis in patients with Peyronie's disease.
Riversi, V., Tallis, Trovatelli, S., Belba, A., Volterrani, L., Iacoponi, F., & Ponchietti, R. (2012) · PubMed · Cited by 24
Cilio, S., Fallara, G., Capogrosso, P., Candela, L., Belladelli, F., Pozzi, E., Corsini, C., Raffo, M., Schifano, N., Boeri, L., et al. (2023) · Andrology · doi:10.1111/andr.13352 · Cited by 21 · cited 4×
“In our results, the mean age of the PD patients was 49.54 years, which is similar to some ages previously reported, averaging 48.2–49.6 years [5,63,64].”
BackgroundResultInfluentialPaulis, G., De Giorgio, G., & Paulis, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415969 · Cited by 21 · cited 2×
“In the scientific literature, several articles have appeared in the 21st century that have clarified the important role that “oxidative stress” plays in the pathophysiology of PD [15–22].”
BackgroundSelf-citationLiguori, G., Salonia, A., Garaffa, G., Chiriacò, G., Pavan, N., Cavallini, G., & Trombetta, C. S. (2018) · International braz j urol · doi:10.1590/s1677-5538.ibju.2017.0418 · Cited by 20
Natale, C., McLellan, D. M., Yousif, A. A., & Hellstrom, W. J. G. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.01.005 · Cited by 19
Trama, F., Illiano, E., Iacono, F., Ruffo, A., Lauro, G. D., Aveta, A., Crocetto, F., Manfredi, C., & Costantini, E. (2022) · Basic and Clinical Andrology · doi:10.1186/s12610-022-00164-w · Cited by 17
Paulis, G., & Cavallini, G. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/18715281113129990055 · Cited by 16 · cited 1×
“In the second phase, known as the chronic “stabilized phase”, penile pain decreases and the plaque size and deformity stabilize [2,15,19,21,22,30,31].”
BackgroundSelf-citationPaulis, G., Cavallini, G., Barletta, D., Turchi, P., Vitarelli, A., & Fabiani, A. (2015) · Research and Reports in Urology · doi:10.2147/rru.s85708 · Cited by 16
Self-citationBajic, P., Wiggins, A. B., Ziegelmann, M. J., & Levine, L. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.02.002 · Cited by 16
Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie’s Disease
Liu, Y., Zheng, D., Liu, X., Shi, X., Shu, S., & Li, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00312 · Cited by 13
Implications of Calcification in Peyronie's Disease, A Review of the Literature
Rainer, Q. C., Rodriguez, A. A., Bajic, P., Galor, A., Ramasamy, R., & Masterson, T. A. (2021) · Urology · doi:10.1016/j.urology.2021.01.007 · Cited by 13
Validation of the Italian version of the Peyronie’s Disease Questionnaire (PDQ)
Traunero, F., Grazia, M. D., Ongaro, L., Rizzo, M., Cocci, A., Verze, P., Zucchi, A., Cai, T., Salamè, L., Garaffa, G., et al. (2023) · International Journal of Impotence Research · doi:10.1038/s41443-023-00792-4 · Cited by 12
Conservative Therapy for Peyronie’s Disease: a Contemporary Review of the Literature
Yousif, A., Natale, C., & Hellstrom, W. J. G. (2021) · Current Urology Reports · doi:10.1007/s11934-020-01024-8 · Cited by 12 · cited 1×
“The therapeutic option indicated for the first phase of PD is conservative medical treatment, which includes oral medications, iontophoresis, intralesional injections, topical creams, shock wave therapy, vacuum penile therapy, and a traction device [32–45].”
BackgroundSonographic patterns of Peyronie's disease in patients with absence of palpable plaques
Dell’Atti, L., & Galosi, A. B. (2018) · International braz j urol · doi:10.1590/s1677-5538.ibju.2017.0298 · Cited by 10
Ultrasound Elastography as a Diagnostic Tool for Peyronie’s Disease: A State-of-the-Art Review
Paulis, G., Giorgio, G. D., & Paulis, A. (2024) · Diagnostics · doi:10.3390/diagnostics14060665 · Cited by 10
Self-citationWong*, A., Tsang, S. S. L., O, R. Y. M., Chun, S., Tsang, C., Ho, B., Ng, A. T. L., Tsu, J. H., & Lam, W. (2020) · The Journal of Urology · doi:10.1097/ju.0000000000000877.012 · Cited by 7
Dullea, A., Efimenko, I., Firdaus, F., Griswold, A., Arora, H., Masterson, T., & Ramasamy, R. (2022) · Urology · doi:10.1016/j.urology.2022.02.023 · Cited by 5 · cited 1×
“PD only affects genetically predisposed males [1,2].”
Zheng, D., Bao, J.-W., Guo, J.-H., Xie, M., Li, W. J., & Wang, Z. (2021) · Asian Journal of Andrology · doi:10.4103/aja.aja_32_21 · Cited by 5
Peyronie’s Disease in People of African Origin: A Mini Review
Kyei, M. Y., Mensah, J. E., Asante, E., Bray, L. D., & Awuku‐Asabre, J. (2017) · Cited by 5
Peyronie’s disease in a district general hospital
Odiase, V., & Whitaker, R. H. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.661.773 · Cited by 4
Trama, F., Riccardo, F., Ruffo, A., Celentano, G., Romeo, G., & Russo, A. (2018) · Open Journal of Urology · doi:10.4236/oju.2018.83009 · Cited by 4
Elastosonography in the Peyronie's disease: our preliminary experience.
Morana, C., Loiero, G., Sangiorgio, A., Zani, T., & Catalano, G. (2010) · PubMed · Cited by 4
Aisuodionoe-Shadrach, O. I. (2014) · PubMed · Cited by 4
Research works printed but not linked: 1
- Wein, 2015, Diagnosis and Management of Peyronie Disease, Campbell-Walsh Urology, Volume 1, 722
Cited by
Zhong, X., Yang, Y., Wei, S., & Liu, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0309849 · Cited by 15
Hashimoto, D., Fujimoto, K., Nakata, M., Suzuki, T., Kumegawa, S., Ueda, Y., Suzuki, K., Asamura, S., & Yamada, G. (2024) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12611 · Cited by 7
Injection therapy in the acute phase of Peyronie’s disease: a systematic review of current evidence
Manfredi, C., Russo, G. I., Capogrosso, P., Falcone, M., Sokolakis, I., Schoentgen, N., Morozov, A., Ortaç, M., Morgado, A., Capece, M., et al. (2025) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdaf044 · Cited by 4
Healing of Peyronie's disease after multimodal antioxidant treatment. A case series
Paulis, G., Giorgio, G. D., & Paulis, A. (2024) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2024.12956 · Cited by 3
Self-citationClinical features and risk factors analysis of diabetes mellitus complicated with Peyronie’s disease
Li, Y., Diao, X., & Wang, Z. (2026) · Sexual Medicine · doi:10.1093/sexmed/qfag012
Metadata
- Authors
- Paulis, G., De Giorgio, G., & Paulis, A.
- Affiliations
- Department of Urology and Andrology, Peyronie’s Care Center, Castelfidardo Clinical Analysis Center, 00185 Rome, Italy
- Section of Ultrasound Diagnostics, Department of Urology and Andrology, Castelfidardo Clinical Analysis Center, 00185 Rome, Italy
- Bambino Gesù Children's Hospital (IT)
- Corresponding author
- Paulis, Gianni
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2024-05-29
- Volume
- 14
- Issue
- 11
- Pages
- 1125
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC11172383
- OpenAlex
- W4399129943
- Cited by
- 11
- References
- 106
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 2
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- Peyronie's disease, penile deformity, penile curvature, erectile dysfunction, penile pain, anxiety, chronic prostatitis, plaque calcification, penile plaque, age-related risk factors, penile ultrasound, psychotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
